Results 21 to 30 of about 524,035 (381)

Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association.

open access: yesCirculation, 2020
Many widely used medications may cause or exacerbate a variety of arrhythmias. Numerous antiarrhythmic agents, antimicrobial drugs, psychotropic medications, and methadone, as well as a growing list of drugs from other therapeutic classes (neurological ...
J. Tisdale   +6 more
semanticscholar   +1 more source

Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19

open access: yesJournal of Clinical Medicine, 2021
Background: Cardiac manifestation of COVID-19 has been reported during the COVID pandemic. The role of cardiac arrhythmias in COVID-19 is insufficiently understood.
Maura M. Zylla   +18 more
semanticscholar   +1 more source

COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies

open access: yesJournal of interventional cardiac electrophysiology, 2020
Background Cardiovascular and arrhythmic events have been reported in hospitalized COVID-19 patients. However, arrhythmia manifestations and treatment strategies used in these patients have not been well-described.
R. Gopinathannair   +10 more
semanticscholar   +1 more source

Arrhythmic risk in elderly patients candidates to transcatheter aortic valve replacement. predicative role of repolarization temporal dispersion [PDF]

open access: yes, 2019
Degenerative aortic valve stenosis (AS) is associated to ventricular arrhythmias and sudden cardiac death, as well as mental stress in specific patients. In such a context, substrate, autonomic imbalance as well as repolarization dispersion abnormalities ...
Crapanzano, Davide   +11 more
core   +1 more source

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

open access: yesNew England Journal of Medicine, 1997
BACKGROUND Patients who survive life-threatening ventricular arrhythmias are at risk for recurrent arrhythmias. They can be treated with either an implantable cardioverter-defibrillator or antiarrhythmic drugs, but the relative efficacy of these two ...
J. Mcanulty   +98 more
semanticscholar   +1 more source

Percutaneous pulmonary valve implantation alters electrophysiologic substrate [PDF]

open access: yes, 2016
BACKGROUND: Percutaneous pulmonary valve implantation (PPVI) is first‐line therapy for some congenital heart disease patients with right ventricular outflow tract dysfunction.
Avari Silva, Jennifer N   +5 more
core   +2 more sources

Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort.

open access: yesEuropean Heart Journal, 2020
AIMS Physical activity reduces cardiovascular disease burden and mortality, although its relationship with cardiac arrhythmias is less certain. The aim of this study was to assess the association between self-reported physical activity and atrial ...
A. Elliott   +10 more
semanticscholar   +1 more source

Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia [PDF]

open access: yes, 2015
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a difficult-to-diagnose cause of sudden cardiac death (SCD). We identified a family of 1400 individuals with multiple cases of CPVT, including 36 SCDs during youth.
Allegue, Catarina   +12 more
core   +2 more sources

Cardiac Arrhythmias in COVID-19 Infection

open access: yesCirculation: Arrhythmia and Electrophysiology, 2020
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19, has affected >1 million people worldwide.1 As of this writing, >60 000 people have died as a result of this virus in the United States alone,2 and New York City
S. Kochav   +9 more
semanticscholar   +1 more source

Cardiac resynchronization therapy and its effects in patients with type 2 DIAbetes mellitus OPTimized in automatic vs. echo guided approach. Data from the DIA-OPTA investigators

open access: yesCardiovascular Diabetology, 2020
Objectives To evaluate the effects of cardiac resynchronization therapy (CRTd) in patients with type 2 diabetes mellitus (T2DM) optimized via automatic vs. echocardiography-guided approach.
Celestino Sardu   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy